SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Steven O’Reilly, Marzena Ciechomska, Nicola Fullard, Stefan Przyborski, Jacob M. van Laar, IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics, Scientific Reports, 2016, 6, 25066

    CrossRef

  2. 2
    Koichi Yanaba, Strategy for treatment of fibrosis in systemic sclerosis: Present and future, The Journal of Dermatology, 2016, 43, 1
  3. 3
    Matlock A Jeffries, Amr H Sawalha, Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve?, Expert Review of Clinical Immunology, 2015, 11, 1, 45

    CrossRef

  4. 4
    Marzena Ciechomska, Jacob Laar, Steven O'Reilly, Current frontiers in systemic sclerosis pathogenesis, Experimental Dermatology, 2015, 24, 6
  5. 5
    Eetmad A. Arafat, Fatma M. Ghoneim, Ayman Z. Elsamanoudy, Fibrogenic gene expression in the skin and lungs of animal model of systemic sclerosis, The Egyptian Journal of Histology, 2015, 38, 1, 21

    CrossRef

  6. 6
    Lara Bossini-Castillo, Elena López-Isac, Maureen D. Mayes, Javier Martín, Genetics of systemic sclerosis, Seminars in Immunopathology, 2015, 37, 5, 443

    CrossRef

  7. 7
    Steven O’Reilly, miRNA-29a in systemic sclerosis: A valid target, Autoimmunity, 2015, 48, 8, 511

    CrossRef

  8. 8
    Hye-Ok Kubo, Douglas Canders, Malcolm Scammells, Philip Frugier, Responses of multiple sclerosis via IL-6/ effectiveness of action, American Journal of BioMedicine, 2015, 3, 4, 188

    CrossRef

  9. 9
    Nicola Fullard, Steven O’Reilly, Role of innate immune system in systemic sclerosis, Seminars in Immunopathology, 2015, 37, 5, 511

    CrossRef

  10. 10
    Carlo Chizzolini, Francesco Boin, The role of the acquired immune response in systemic sclerosis, Seminars in Immunopathology, 2015, 37, 5, 519

    CrossRef

  11. 11
    M Ciechomska, J M van Laar, S O'Reilly, Emerging role of epigenetics in systemic sclerosis pathogenesis, Genes and Immunity, 2014, 15, 7, 433

    CrossRef

  12. 12
    Steven O'Reilly, Rachel Cant, Marzena Ciechomska, James Finnigan, Fiona Oakley, Sophie Hambleton, Jacob M. Laar, Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-κB, Immunology, 2014, 143, 3
  13. 13
    Steven O'Reilly, Role of interleukin-13 in fibrosis, particularly systemic sclerosis, BioFactors, 2013, 39, 6
  14. 14
    Andreas Reiff, Kenneth I. Weinberg, Timothy Triche, Bernadette Masinsin, Kris M. Mahadeo, Chuan-Hao Lin, Diane Brown, Robertson Parkman, T lymphocyte abnormalities in juvenile systemic sclerosis patients, Clinical Immunology, 2013, 149, 1, 146

    CrossRef

  15. 15
    Rachel Cant, Jacob M van Laar, Steven O’Reilly, Therapeutic targeting of T cells in systemic sclerosis, International Journal of Clinical Rheumatology, 2013, 8, 3, 373

    CrossRef